Agatonovic-Kustrin S, Tucker I G, Schmierer D
School of Pharmacy, University of Otago, Dunedin, New Zealand.
Pharm Res. 1999 Sep;16(9):1477-82. doi: 10.1023/a:1018975730945.
A new, simple, sensitive and rapid method was developed to analyse the polymorphic purity of crystalline ranitidine-HCI as a bulk drug and from a tablet formulation.
Diffuse reflectance infrared Fourier transform (DRIFT) spectroscopy was combined with Artificial Neural Networks (ANNs) as a data modelling tool. A standard feed-forward network, with backpropagation rule and with single hidden layer architecture was chosen. Reduction and transformation of the spectral data enhanced the ANN performance and reduced the complexity of the ANNs model. Spectral intensities from 1738 wavenumbers were reduced into 173 averaged spectral values. These 173 values were used as inputs for the ANN. Following a sensitivity analysis the number of inputs was reduced to 30, or 35, these being the input windows which had most effect on the output of the ANN.
For the bulk drug assay, the ANN model had 30 inputs selected from a sensitivity analysis, one hidden layer, and two output neurons, one for the percentage of each ranitidine hydrochloride crystal form. The model could simultaneously distinguish between crystal forms and quantify them enabling the physical purity of the bulk drug to be checked. For the tablet assay, the ANN model had 173 averaged spectral values as the inputs, one hidden layer and five output neurons, two for the percentage of the two ranitidine hydrochloride crystal forms and three more outputs for tablet excipients and additives. The ANN was able to solve the problem of overlapping peaks and it successfully identified and quantified all components in tablet formulation with reasonable accuracy.
Some of the advantages over conventional analytical methods include simplicity, speed and good selectivity. The results from DRIFT spectral quantification study show the benefits of the neural network approach in analysing spectral data.
开发一种新的、简单、灵敏且快速的方法,用于分析作为原料药及片剂制剂的结晶盐酸雷尼替丁的多晶型纯度。
将漫反射红外傅里叶变换(DRIFT)光谱与人工神经网络(ANNs)相结合作为数据建模工具。选择了具有反向传播规则和单隐藏层架构的标准前馈网络。光谱数据的约简和变换提高了人工神经网络的性能并降低了人工神经网络模型的复杂性。将1738波数处的光谱强度约简为173个平均光谱值。这173个值用作人工神经网络的输入。经过敏感性分析后,输入数量减少到30个或35个,这些是对人工神经网络输出影响最大的输入窗口。
对于原料药分析,人工神经网络模型从敏感性分析中选择30个输入、一个隐藏层和两个输出神经元,一个用于每种盐酸雷尼替丁晶型的百分比。该模型能够同时区分晶型并对其进行定量,从而能够检查原料药的物理纯度。对于片剂分析,人工神经网络模型以173个平均光谱值作为输入、一个隐藏层和五个输出神经元,两个用于两种盐酸雷尼替丁晶型的百分比,另外三个输出用于片剂辅料和添加剂。人工神经网络能够解决峰重叠问题,并以合理的准确度成功识别和定量片剂制剂中的所有成分。
相对于传统分析方法的一些优点包括简单、快速和良好的选择性。DRIFT光谱定量研究的结果显示了神经网络方法在分析光谱数据方面的优势。